期刊文献+

卡维地洛和美托洛尔对高血压性心脏病患者心肌质量的影响 被引量:2

Effects of Carvediolol and Uetoprold on the Quality of Myocardium in Patients with Hypertensive Heart Disease
原文传递
导出
摘要 目的观察β受体阻滞剂卡维地洛和美托洛尔对高血压性心脏病患者左室心肌质量的影响。方法将2005年6月-2007年6月收治的260例原发性高血压性心脏病患者,随机分为A、B两组,每组130例。均停用其他降压药物1周后,A组服用卡维地洛,B组服用美托洛尔。两组第1周均服用12.5 mg,2次/d;无明显心动过缓或血压明显下降者,第2周改服25 mg,2次/d,必要时均加用硝苯地平控释片以血压降低至正常范围,心率≥55次/min为宜,每2周加量,最大剂量为50 mg,2次/d。疗程6个月。观察指标:分别于用药前后测定患者左室舒张末内径(LVDd)、左室射血分数(LVEF)、室间隔厚度(LVST)及左室后壁厚度(PWT)。计算左室心肌质量(LVMW)、左室心肌质量指数(LVWI)。结果 A、B两组在试验前后分别作自身对比,LVDd减小,LVST及PWT变薄,LVEF增高,LVWI降低差异有统计学意义(P<0.01);A、B两组在试验后对比,差异无统计学意义(P>0.05)。结论卡维地洛、美托洛尔应用于高血压心脏病患者,可有效降低血压和减慢心率,减少心肌耗氧量,降低左室负荷及神经激素的活动,减轻左室肥厚,减低心肌质量。 Objective To observe the effects of β-receptor blockers on left ventricular myocardial mass in patients with hypertensive heart disease.Methods A total of 260 patients with primary hypertensive heart disease treated between June 2005 and June 2007 were enrolled in our study,and they were randomly divided into two groups,with 130 in each group.One week after other antihypertensive drugs were discontinued,group A began to take small dose of carvedilol,while group B took small dose of metoprolol tablets.In the first week,the dosage was 12.5 mg,bid.For patients without too slow heartbeat or significant blood pressure decrease,the dosage was changed to 25mg,bid in the second week,and when necessary,nifedipine controlled release tablets were added to decrease blood pressure to normal range.The heart rate should not be less than 55 times/min.Every two weeks,we increased the dose,and the maximum dose was 50 mg,bid.The course of treatment was 6 months.Before and after treatment,we measured left ventricular end diastolic diameter(LVDd),left ventricular ejection fraction(LVEF),interventricular septal thickness(LVST) and left ventricular posterior wall thickness(PWT) of the patients.We performed the calculation of myocardial mass of left ventricle(LVW),and according to height and weight,we calculated the body surface area(BSA),and left ventricular mass index(LVWI).Results The two groups were compared before and after the experiment respectively.The LVDd decreased,LVST and left ventricular PWT became thin.LVEF increased.LVWI decreased from(133.58 ± 8.69)g/m2 to(109.22 ± 23.51)g/m2 after the treatment,and the difference was statistically significant(P0.01).Group A patients had shorter LVDd,lower LVST and left ventricular PWT,and higher LVEF than patients in group B.LVWI decreased,but the difference was not significant.Conclusions β-receptor blockers in hypertension patients with heart disease can effectively reduce blood pressure,heart rate,myocardial oxygen consumption,left ventricular load,neurohormonal activity,and left ventricular hypertrophy,and myocardial mass.Carvedilol as a new comprehensive adrenaline receptor blocker seems to have more advantages than metoprolol,but there is no statistical evidence at present.
出处 《华西医学》 CAS 2013年第8期1186-1189,共4页 West China Medical Journal
关键词 Β受体阻滞剂 卡维地洛 美托洛尔 高血压 心肌质量 β-receptor blockers Carvedilol Uetoprolol Hypertension Quality of myocardium
  • 相关文献

参考文献12

  • 1孙跃民,姚微,黄灿亮,等.高血压病患者脉压与靶器官损害的关系[J].中华医学杂志,2006,6:86-87.
  • 2Doughty RN,Whalley GA,Gamble G,et al.Leftventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease[J].J Am Coll Cardiol,1997,29(5):1060-1066.
  • 3Packer M,Coats AJ,Fowler MB,et al.Effect of carvedilol onsurvivalin severe chronic heart failure[J].N Engl J Med,2001,344(22):1651-1658.
  • 4刘力生,黄兰生.中国高血压防治指南(2005年修订版)[M].北京:中国高血压防治指南修订委员会,2005.
  • 5王明屹,胡镇祥.脉冲波多普勒超声心动图评价冠心病左室舒张功能[J].中华心血管病杂志,1992,20(6):341-343. 被引量:10
  • 6胡小玲,周薇,鲍卫东,林娜,佟铭,王善伯,蒲英.高血压和肥胖对男性老年人左室重量和几何形状的影响[J].中国循环杂志,1993,8(12):708-709. 被引量:4
  • 7赵郁珍,丁绍平,胡东升.卡维地洛治疗老年慢性心力衰竭患者的临床观察[J].中华老年心脑血管病杂志,2003,5(5):307-308. 被引量:5
  • 8胡琴,耿邵华,李隆贵.卡维地洛心肌保护作用的理论基础[J].心血管病学进展,2003,24(2):107-110. 被引量:17
  • 9McMurray J,K?ber L,Robertson M,et al.Antiarrhythmic effect of carvedilol after acute myocardial infarction:results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (Capricorn) trial[J].J Am Coll Cardiol,2005,45(4):525-530.
  • 10张抒扬 戴玉华.全国高血压左室肥厚临床及基础研讨会纪要[J].中华内科杂志,1994,33(2):139-140.

二级参考文献42

  • 1王阿力 杨庭树.新型β受体阻滞剂治疗心力衰竭初步临床观察[J].临床心血管病杂志,2000,17:27-30.
  • 2[1]Sackner-Bemstein JD. Use of carvedilol in chronic heart failure: challenges in therapeutic management[ J ]. Prog Cardiovasc Dis, 1998,41 (suppl 1 ) :s53-s58.
  • 3[2]Zweier JL. Measurement of superoxied derived free radicals inthe reperfused heart:Evidence Rui MV. Abreu, Dario JS. Santos,Antonio JM. Moreno for a free radical mechanism of reperfusion injury [J]. J Biol Chem, 1988,263: 1353-1357.
  • 4[3]Cheng H Y, Randall CS, Holl WW, et al. Carvedilol-liposome interaction:evidence for strong association with the hydrophobic region of the lipid bilayers[J]. Biochem Biophys Acta, 1996,128:20-28.
  • 5[4]Yue TL,Mckenna PJ,Gu JL,et al. Carvedilol,a new antihypertensive agent,prevents lipid peroxidation and oxidation injury to endothelial cells [J]. Hypertension, 1993,22:922-928.
  • 6[5]Yue TL, Liu T, Feuerstein GZ. Carvedilol, a new bets adrenoceptor antagonist and vasodilator antihypoertensive drug, inhibits oxygen-radical-mediated lipid peroxidation in swine ventricular membranes [J]. Pharmacol Commun, 1992,1:27-35.
  • 7[6]Yue TL,Wang X.Gu JL,et al. Carvedilol,a new vasodilating β-adrenoceptor anagonist, prevents low-density lipoprotein (LDL)-enhanced leukocyte adhesion to endothelial cells by inhibition of LDL oxidation [J]. Eur J Pharmacol, 1995,294:585-591.
  • 8[7]Yue TL, Mckenna PJ, Ruffolo RR Jr,et al. Carvedilol,a new β-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils [J]. Eur J Pharmacol, 1992,214: 277 -280.
  • 9[8]Christopher TG, Lopez BL,Ma XL,et al. Effects of a hydroxylated metabolite of the β-adrenoceptor antagonist,carvedilol,on post-ischaemic splanchnic tissue injury [J]. Br J Pharmacol, 1998,123: 292 -298.
  • 10[9]Abreu RMV ,Santos DJSL,Moreno AJM. Effects of Carvediol and its analog BM910228 on mitochondrial function and oxidative stress [ J ]. J Pharmacol Exp Therapeut ,2000,295:1022-1030.

共引文献119

同被引文献29

  • 1周俊彦,王玉堂,单兆亮.心脏迷走神经与心房颤动关系的研究进展[J].中华老年心脑血管病杂志,2006,8(10):715-716. 被引量:3
  • 2Yanowitz F,preston JB, Abildskov JA. Functional distribution ofright and left stellate innervation to the ventricles. Production ofneurogenic electrocardiographic changes by unilateral alterationof sympathetic tone [J]. Circ Res,1966,18( 4): 416 - 428.
  • 3Brandys JC,Hopkins DA,Armour JA. Cardiac responses to stim-ulation of discrete loci within canine sympathetic ganglia follow-ing heaxamethonium[J]. J Auton Nerv Syst, 1984,11 (3) : 243 -255.
  • 4吕靖,谷婧丽,修芸,等.心脏交感神经递质释放的电化学研究.中国生理学会循环生理学专业委员会.2012中国生理学会心血管生理学术研讨会论文汇编[C].北京:中国生理学会循环生理学专业委员会,2012.
  • 5Chiou CW’Eble J’Zipes D. Efferent vagal innervation of the ca-nineatria and sinus and atrioventricular nodes:The third fat pad[J]. Circulation, 1997,95:2573 - 2584.
  • 6Zhang Y,Popvoic ZB,Bibevski S, et al. Chronic vagus nervestimulation improves autonomic control and attenuates systemicinflammation and heart failure progression in a canine high -rate pacing model [J]. Circ Heart Fail,2009.2: 692 - 699.
  • 7Levick SP, Murray DB’Janicki JS, et al. Sympathetic nervoussystem modulation of inflammation and remodeling in the hyper-tensive heart[J]. Hypertension,2010,55(2) :270-276.
  • 8Guido G,Gino S, Fosca QT. The neuroadrenergic hypothesis inhypertension: Current evidence[J]. Exp Physiol,2010,95(2):581 - 586 .
  • 9Sato K , Urbnao R ,Yu C. etal. Protective effect of donepezil oncardiovascular mortality[J]. Circulation, 2008,117: e269.
  • 10Okazaki Y,Zheng C,Li M,et al. Effect of the cholinesterase in-hibitor donepezil on cardiac remodeling ang autonomic balancein rats with heart failure [J]. J Physiol Sci,2010,60:67 - 74.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部